ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
•18 Nov 2018 14:21

Low Tide on Aussie Growth Stocks

Growth isn’t Dead Yet. Value’s outperformance in the past couple of months is relatively small compared to past periods and we think the...

Logo
527 Views
Share
•20 Oct 2018 08:35

It’s Not Over Yet, but Lift the Bar on Defence

A Correction and Not the End of the Cycle. In our view, the equity market sell-off in the past few weeks is a correction and a return to more...

Logo
606 Views
Share
•30 Sep 2018 06:56

Aussie Equities Month in Review (Sept 2018)

Giving Back Reporting Season Gains. In our view, reporting season was relatively solid, with 8% EPS growth achieved in FY18 and another 8%...

Logo
498 Views
Share
•26 Sep 2018 18:37

Aussie Equities Model Portfolio Update

Good outperformance by staying long growth. Our model portfolio has a tilt towards Growth over Value and this has underpinned its solid...

Logo
548 Views
Share
bullish•MSCI ACWI Index
•07 Sep 2018 20:32

Bottoms-Up View on Developed Markets: Actionable Stocks, Part 2

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index.  In today’s report...

Logo
643 Views
Share
x